Mark For: CLIPS® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 90532381 |
Registration Number | 6777571 |
Mark Literal Elements | CLIPS |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Trademark, Service Mark |
Current Location | NEW APPLICATION PROCESSING 2021-02-20 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Michael M. Morris |
Attorney Docket Number | 84119-2 |
2009-06-30 | Date of First Use |
2009-06-30 | Date of Use In Commerce |
2021-02-17 | Application Filed |
2021-02-20 | Location: NEW APPLICATION PROCESSING |
2021-02-20 | Status: Live/Pending |
2021-02-20 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
2021-02-20 | Transaction Date |
2022-07-05 | Trademark Registered |
Party: | ![]() |
Address | Zuidersluisweg 2 Lelystad NETHERLANDS 8243RC |
Legal Entity Type | Limited Liability Company |
Legal Entity State | NETHERLANDS |
![]() | MULTI | 2021-02-17 |
![]() | JPEG | 2021-02-17 |
![]() | JPEG | 2021-02-17 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Synthetic peptides for pharmaceutical purposes; peptides; pharmaceutical preparations based on peptides; antibodies; mimics for antibodies |
GS0051 | Synthetic peptides for pharmaceutical purposes in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Synthetic peptides for the treatment of cancer, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders ; pharmaceutical preparations based on peptides in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Diagnostic kits consisting primarily of monoclonal antibodies or mimics thereof consisting of peptides, buffers, and reagents for use in disease testing; mimics consisting of peptides for antibodies |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2021-02-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.